TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
FHTX

Foghorn Therapeutics Inc

Healthcare · Biotechnology

4.20$ +0.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Foghorn Therapeutics Inc (FHTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 47.3% of the shares are freely tradable; institutional investors hold 76.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 76.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 17.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 47.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 59Mio.

Largest Shareholders

Institutions

Institutions FHTX
Name Stake (%) Shares Change (%) Date
Flagship Ventures Management, Inc. 21.34 12,674,120 +0.0 06/30/2026
FMR Inc 10.18 6,047,198 +12.1 03/31/2026
Bvf Inc 9.84 5,842,000 +10.2 03/31/2026
Deerfield Management Co 7.40 4,394,367 +20.4 03/31/2026
BlackRock Inc 3.98 2,364,866 +0.6 03/31/2026
Euclidean Capital LLC 2.65 1,573,761 +0.0 06/30/2026
Vanguard Capital Management, LLC 2.52 1,495,089 +0.0 03/31/2026

Funds

Funds FHTX
Name Stake (%) Shares Change (%) Date
Fidelity Growth Compy Commingled Pl S 4.59 2,724,078 +0.0 07/31/2026
Fidelity Growth Company Fund 3.09 1,834,180 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 1.75 1,040,679 +1.3 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?